Fig. 4From: Potential ‘anti-cancer’ effects of esketamine on proliferation, apoptosis, migration and invasion in esophageal squamous carcinoma cellsEsketamine treatment reduced the migration and invasion capabilities of esophageal squamous carcinoma cells (ESCC). Transwell invasion assay was implemented to examine the invasive ability of the KYSE-30 cells and KYSE-150 cells (A). Wound healing assays were conducted to detect the migratory of KYSE-30 cells (B) and KYSE-30cells (C). The migratory ratio was calculated by dividing the wound area by total area. Data are presented as mean ± SEM; **P < 0.01, ***P < 0.001 vs the control groupBack to article page